491 related articles for article (PubMed ID: 34742369)
1. Estimating total spending by source of funding on routine and supplementary immunisation activities in low-income and middle-income countries, 2000-17: a financial modelling study.
Ikilezi G; Micah AE; Bachmeier SD; Cogswell IE; Maddison ER; Stutzman HN; Tsakalos G; Brenzel L; Dieleman JL
Lancet; 2021 Nov; 398(10314):1875-1893. PubMed ID: 34742369
[TBL] [Abstract][Full Text] [Related]
2. Tracking total spending on tuberculosis by source and function in 135 low-income and middle-income countries, 2000-17: a financial modelling study.
Su Y; Garcia Baena I; Harle AC; Crosby SW; Micah AE; Siroka A; Sahu M; Tsakalos G; Murray CJL; Floyd K; Dieleman JL
Lancet Infect Dis; 2020 Aug; 20(8):929-942. PubMed ID: 32334658
[TBL] [Abstract][Full Text] [Related]
3. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050.
Global Burden of Disease 2020 Health Financing Collaborator Network
Lancet; 2021 Oct; 398(10308):1317-1343. PubMed ID: 34562388
[TBL] [Abstract][Full Text] [Related]
4. Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995-2050.
Global Burden of Disease Health Financing Collaborator Network
Lancet; 2019 Jun; 393(10187):2233-2260. PubMed ID: 31030984
[TBL] [Abstract][Full Text] [Related]
5. Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995-2015.
Global Burden of Disease Health Financing Collaborator Network
Lancet; 2018 May; 391(10132):1799-1829. PubMed ID: 29678342
[TBL] [Abstract][Full Text] [Related]
6. Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study.
Haakenstad A; Moses MW; Tao T; Tsakalos G; Zlavog B; Kates J; Wexler A; Murray CJL; Dieleman JL
Lancet HIV; 2019 Jun; 6(6):e382-e395. PubMed ID: 31036482
[TBL] [Abstract][Full Text] [Related]
7. Evolution and patterns of global health financing 1995-2014: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries.
Global Burden of Disease Health Financing Collaborator Network
Lancet; 2017 May; 389(10083):1981-2004. PubMed ID: 28433256
[TBL] [Abstract][Full Text] [Related]
8. National spending on health by source for 184 countries between 2013 and 2040.
Dieleman JL; Templin T; Sadat N; Reidy P; Chapin A; Foreman K; Haakenstad A; Evans T; Murray CJ; Kurowski C
Lancet; 2016 Jun; 387(10037):2521-35. PubMed ID: 27086174
[TBL] [Abstract][Full Text] [Related]
9. Future and potential spending on health 2015-40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries.
Global Burden of Disease Health Financing Collaborator Network
Lancet; 2017 May; 389(10083):2005-2030. PubMed ID: 28433260
[TBL] [Abstract][Full Text] [Related]
10. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3.
Global Burden of Disease Health Financing Collaborator Network
Lancet; 2020 5-11 Sep; 396(10252):693-724. PubMed ID: 32334655
[TBL] [Abstract][Full Text] [Related]
11. Funding gap for immunization across 94 low- and middle-income countries.
Ozawa S; Grewal S; Portnoy A; Sinha A; Arilotta R; Stack ML; Brenzel L
Vaccine; 2016 Dec; 34(50):6408-6416. PubMed ID: 28029541
[TBL] [Abstract][Full Text] [Related]
12. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
Peny JM; Gleizes O; Covilard JP
Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
[TBL] [Abstract][Full Text] [Related]
13. Trends in future health financing and coverage: future health spending and universal health coverage in 188 countries, 2016-40.
Global Burden of Disease Health Financing Collaborator Network
Lancet; 2018 May; 391(10132):1783-1798. PubMed ID: 29678341
[TBL] [Abstract][Full Text] [Related]
14. Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).
Le Gargasson JB; Breugelmans JG; Mibulumukini B; Da Silva A; Colombini A
Vaccine; 2013 Apr; 31(15):1886-91. PubMed ID: 23462529
[TBL] [Abstract][Full Text] [Related]
15. Tracking spending on malaria by source in 106 countries, 2000-16: an economic modelling study.
Haakenstad A; Harle AC; Tsakalos G; Micah AE; Tao T; Anjomshoa M; Cohen J; Fullman N; Hay SI; Mestrovic T; Mohammed S; Mousavi SM; Nixon MR; Pigott D; Tran K; Murray CJL; Dieleman JL
Lancet Infect Dis; 2019 Jul; 19(7):703-716. PubMed ID: 31036511
[TBL] [Abstract][Full Text] [Related]
16. Costs of vaccine programs across 94 low- and middle-income countries.
Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
[TBL] [Abstract][Full Text] [Related]
17. Vaccine Assistance To Low- And Middle-Income Countries Increased To $3.6 Billion In 2014.
Haakenstad A; Birger M; Singh L; Liu P; Lim S; Ng M; Dieleman JL
Health Aff (Millwood); 2016 Feb; 35(2):242-9. PubMed ID: 26858376
[TBL] [Abstract][Full Text] [Related]
18. Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011-2020.
Gandhi G; Lydon P; Cornejo S; Brenzel L; Wrobel S; Chang H
Vaccine; 2013 Apr; 31 Suppl 2():B137-48. PubMed ID: 23598475
[TBL] [Abstract][Full Text] [Related]
19. Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study.
Hartner AM; Li X; Echeverria-Londono S; Roth J; Abbas K; Auzenbergs M; de Villiers MJ; Ferrari MJ; Fraser K; Fu H; Hallett T; Hinsley W; Jit M; Karachaliou A; Moore SM; Nayagam S; Papadopoulos T; Perkins TA; Portnoy A; Minh QT; Vynnycky E; Winter AK; Burrows H; Chen C; Clapham HE; Deshpande A; Hauryski S; Huber J; Jean K; Kim C; Kim JH; Koh J; Lopman BA; Pitzer VE; Tam Y; Lambach P; Sim SY; Woodruff K; Ferguson NM; Trotter CL; Gaythorpe KAM
Lancet Glob Health; 2024 Apr; 12(4):e563-e571. PubMed ID: 38485425
[TBL] [Abstract][Full Text] [Related]
20. Financing And Funding Gap For 16 Vaccines Across 94 Low- And Middle-Income Countries, 2011-30.
Sriudomporn S; Sim SY; Mak J; Brenzel L; Patenaude BN
Health Aff (Millwood); 2023 Jan; 42(1):94-104. PubMed ID: 36623227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
